Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes

Diabetes Care

Volumn 27, Issue 8, 2004, Pages 1991-1997

  Jiang, Rui ^a   Schulze, Matthias B ^a   Li, Tricia ^a   Rifai, Nader ^c   Stampfer, Meir J ^a,b   Rimm, Eric B ^a,b   Hu, Frank B ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; EVALUATION; FOLLOW UP; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONBIOLOGICAL MODEL; PREDICTION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; UNITED STATES;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; TRIGLYCERIDES;

EID: 3342958811     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.8.1991     Document Type: Article

References (25)

1. Garg A, Grundy SM: Management of dyslipidemia in NIDDM. Diabetes Care 13: 153-169, 1990
2. Grundy SM: Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation 106:2526-2529, 2002
3. Hsia SH: Non-HDL cholesterol: into the spotlight. Diabetes Care 26:240-242, 2003
4. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
5. Abate N, Vega GL, Grundy SM: Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100. Atherosclerosis 104:159-171, 1993
6. Frost PH, Davis BR, Burlando AJ, Curb JD, Guthrie GP Jr, Isaacsohn JL, Wassertheil-Smoller S, Wilson AC, Stamler J: Serum lipids and incidence of coronary heart disease: findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation 94:2381-2388, 1996
7. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL: Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161:1413-1419, 2001
8. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, Stampfer MJ: Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 338:464-468, 1991
9. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
11. Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB: Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 161:1542-1548, 2001
12. Rose G, Blackburn H: Cardiovascular Survey Methods. Geneva, World Health Organization, 1982 (monogr. no. 58)
13. Walker AE, Robins M, Weinfeld FD: The National Survey of Stroke: clinical findings. Stroke 12 (Supp. 1):113-144, 1981
14. Rich-Edwards JW, Corsano KA, Stampfer MJ: Test of the National Death Index. Am J Epidemiol 119:837-839, 1984
15. Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, Rosner B, Cramer D, Hennekens CH: Cigarette smoking, relative weight, and menopause. Am J Epidemiol 117:651-658, 1983
16. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, John Wiley & Sons, 2000
17. Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, Robbins DC, Howard BV: Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the Strong Heart Study. Diabetes Care 26:16-23, 2003
18. Lehto S, Ronnemaa T, Haffner SM, Pyorala K, Kallio V, Laakso M: Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 46:1354-1359, 1997
19. Sniderman AD: Counterpoint: to (measure apo) B or not to (measure apo) B: a critique of modern medical decision-making. Clin Chem 43:1310-1314, 1997
20. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
21. Kinosian B, Glick H, Garland G: Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 121:641-647, 1994
22. Kinosian B, Glick H, Preiss L, Puder KL: Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. J Investig Med Oct 43:443-450, 1995
23. Kannel WB, Wilson PW: Efficacy of lipid profiles in prediction of coronary disease. Am Heart J 124:768-774, 1992
24. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE: Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women. Am J Cardiol 68:1646-1650, 1991
25. Criqui MH, Golomb BA: Epidemiologic aspects of lipid abnormalities. Am J Med 105:48S-57S, 1998